This is the authors' abstract. We don't add key points for this paper.
P eople with diabetes constitute a tar-get group for influenza vaccinationsince they are currently thought to run a high risk of suffering influenza-related complications (1–3). Influenza vaccination has shown it-self to be capable of producing an ade-quate immunologic response in subjects with diabetes, proving effective in reduc-ing mortality and morbidity in patients with underlying chronic diseases, includ-ing diabetes, and reducing hospital ad-missions among diabetic patients during influenza epidemics (3–8). For over a decade, Spanish and U.S. health authorities been recommending annual influenza vaccination for subjects
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Jiménez‐García et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: